6-K

INNATE PHARMA S.A. FORM 6-K

Company: Innate Pharma SA
Filed: January 24, 2022
Period of Report: January 24, 2022
Accession Number: 0001157523-22-000080

View Document ↗ View on SEC.gov ↗